Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | BMC Cancer

Figure 3

From: Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

Figure 3

Expression and localisation of P-JAK2 and T-JAK2 in ascites-derived tumor cells in response to paclitaxel treatment. The images were evaluated as described in Figure 1. Images are representative of four independent experiments from four patient samples. The mean fluorescence intensity of P-JAK2 and T-JAK2 was quantified using Cell-R software. Significant intergroup variations are indicated by ***P < 0.001. Magnification 200×; scale bar = 10 μM.

Back to article page